JP2021517587A5 - - Google Patents

Download PDF

Info

Publication number
JP2021517587A5
JP2021517587A5 JP2020557373A JP2020557373A JP2021517587A5 JP 2021517587 A5 JP2021517587 A5 JP 2021517587A5 JP 2020557373 A JP2020557373 A JP 2020557373A JP 2020557373 A JP2020557373 A JP 2020557373A JP 2021517587 A5 JP2021517587 A5 JP 2021517587A5
Authority
JP
Japan
Prior art keywords
cancer
tumor
use according
til
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020557373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021517587A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/070944 external-priority patent/WO2019137384A1/en
Publication of JP2021517587A publication Critical patent/JP2021517587A/ja
Publication of JP2021517587A5 publication Critical patent/JP2021517587A5/ja
Priority to JP2024000217A priority Critical patent/JP2024050573A/ja
Pending legal-status Critical Current

Links

JP2020557373A 2018-01-09 2019-01-09 腫瘍浸潤リンパ球(tils)を活性化する方法 Pending JP2021517587A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024000217A JP2024050573A (ja) 2018-01-09 2024-01-04 腫瘍浸潤リンパ球(tils)を活性化する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862615300P 2018-01-09 2018-01-09
US62/615,300 2018-01-09
PCT/CN2019/070944 WO2019137384A1 (en) 2018-01-09 2019-01-09 Method of activating tumor-infiltrating lymphocytes (tils)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024000217A Division JP2024050573A (ja) 2018-01-09 2024-01-04 腫瘍浸潤リンパ球(tils)を活性化する方法

Publications (2)

Publication Number Publication Date
JP2021517587A JP2021517587A (ja) 2021-07-26
JP2021517587A5 true JP2021517587A5 (cg-RX-API-DMAC7.html) 2022-01-11

Family

ID=67139037

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020557373A Pending JP2021517587A (ja) 2018-01-09 2019-01-09 腫瘍浸潤リンパ球(tils)を活性化する方法
JP2024000217A Pending JP2024050573A (ja) 2018-01-09 2024-01-04 腫瘍浸潤リンパ球(tils)を活性化する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024000217A Pending JP2024050573A (ja) 2018-01-09 2024-01-04 腫瘍浸潤リンパ球(tils)を活性化する方法

Country Status (6)

Country Link
US (1) US11179425B2 (cg-RX-API-DMAC7.html)
EP (2) EP3737395A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021517587A (cg-RX-API-DMAC7.html)
CN (1) CN111655272A (cg-RX-API-DMAC7.html)
TW (1) TWI817977B (cg-RX-API-DMAC7.html)
WO (1) WO2019137384A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119868398A (zh) * 2018-06-14 2025-04-25 株式会社明治 用于促进免疫检查点抑制疗法的组合物
JP7856975B2 (ja) 2022-09-12 2026-05-12 賢一郎 蓮見 抗腫瘍免疫応答増強剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
DE60134386D1 (de) 2001-03-21 2008-07-24 Microbio Co Ltd Verfahren zur Hemmung von Krebswachstum mit einem fermentierten Soja- Extrakt
JP2003335695A (ja) * 2002-05-17 2003-11-25 Nippon Bio Kk 大豆発酵物よりなる免疫増強剤、抗腫瘍剤、加工食品および大豆発酵物の製造方法
TWI252759B (en) 2002-07-05 2006-04-11 Microbio Co Ltd Method of using fermented glycine max (L.) extract for enhancing natural killer cell activity
CN100352459C (zh) 2004-07-15 2007-12-05 中天生物科技股份有限公司 发酵大豆萃取液在制备药物中的应用
SG187554A1 (en) 2010-07-20 2013-03-28 Microbio Co Ltd Use of a fermented soy extract for manufacture of a prebiotic composition
EP2659898B1 (en) * 2010-12-28 2018-03-07 Kirin Holdings Kabushiki Kaisha Use of lactococcus bacteria in the treatment or prevention of viral infections
JP2015051970A (ja) 2013-09-06 2015-03-19 マイクロバイオ カンパニー, リミテッド 化学療法を受けているがん患者向けのアジュバントを製造するための組成物
EA201690912A1 (ru) * 2013-11-05 2016-10-31 Когнейт Биосервисис, Инк. Комбинации ингибиторов контрольных точек и терапевтических средств для лечения рака
KR20180126053A (ko) * 2016-03-30 2018-11-26 마이크로바이오 컴퍼니 엘티디. 면역 체크포인트 조절제 및 공생 미생물군에 의한 발효 산물로의 병용 암 치료법
EP3228701A1 (en) * 2016-04-05 2017-10-11 Fundación Centro Nacional de Investigaciones Oncológicas Carlos III Method for preparing lymphocytes capable of infiltrating a solid tumor, lymphocytes obtainable by said method and uses thereof
CN112779217B (zh) * 2021-03-29 2023-04-11 复旦大学附属中山医院 一种高记忆表型肿瘤浸润t淋巴细胞的培养方法

Similar Documents

Publication Publication Date Title
CN109294985B (zh) 一种用于nk细胞体外扩增的培养基体系及nk细胞体外扩增的方法
CN103756963B (zh) 一种体外扩增nk细胞的方法
IL274584B2 (en) Infiltrating lymphocyte expansion from fine needle aspirates and small biopsies
CN105238754B (zh) 一种高增殖力和高杀伤力nk细胞的体外培养方法
CN104781413B (zh) 用于具有肺炎球菌血清型的荚膜多糖的生产方法
CN105039269A (zh) 一种用于治疗非小细胞肺癌的新型病毒疫苗及其制备方法
CN112779217B (zh) 一种高记忆表型肿瘤浸润t淋巴细胞的培养方法
CN106591232A (zh) 一种高效的pd‑1‑cd8+t细胞的培养方法
RU2014147735A (ru) Онколитические штаммы clostridium ghonii, способы получения и применения
CN105505871B (zh) 一种有效扩增cik且提高其特异性杀瘤能力的方法
CN107502591A (zh) 一种浓度梯度rhIL‑2依赖的iNKT细胞扩增方法及其应用
JP2018531016A5 (cg-RX-API-DMAC7.html)
JP2018505666A5 (cg-RX-API-DMAC7.html)
CN111662870A (zh) 卡介菌多糖核酸在cik细胞体外培养及制备肿瘤药物中的应用
US9950020B2 (en) Extracts from fusarium oxysporum and use thereof
CN110205293A (zh) 一种加强型高效治疗肺癌的nk免疫细胞的制备方法及应用
CN112695014A (zh) 一种扩增nk细胞的培养体系及其培养方法
CN104651312A (zh) 一种高效免疫活性细胞CpG-DCIK的制备方法及应用
CN104906088B (zh) 黄连素在制备治疗t细胞淋巴瘤的药物中的应用
CN105505870A (zh) 免疫细胞培养方法以及人工滋养细胞在免疫细胞培养中的用途
CN105219728A (zh) 一种用于激活乳腺癌特异性免疫反应的试剂盒
Peng et al. Induction of cytotoxic T-lymphocyte responses using dendritic cells transfected with hepatocellular carcinoma mRNA
WO2020037120A4 (en) Il7-il15 txm compositions and methods
VIDYA et al. Spirulina, the boon of nature
CN105219715A (zh) 一种用于激活食管癌特异性免疫反应的试剂盒